Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 31st International Symposium on Intensive Care and Emergency Medicine (ISICEM)
First-line Therapies for MRSA Pneumonia in the ICU: Emerging Standard
Brussels, Belgium / March 22-25, 2011
According to data from a double-blind, randomized, multicentre comparison, the two most commonly recommended antibiotics for control of methicillin-resistant Staphylococcus aureus (MRSA) in the intensive-care unit (ICU) did not appear to...
PRIORITY PRESS - 31st International Symposium on Intensive Care and Emergency Medicine (ISICEM)
More Rapid Measures Needed to Confirm and Treat Aspergillosis Infections
Brussels, Belgium / March 22-25, 2011
There have been incremental improvements in a variety of diagnostic tools for identifying fungal infection, including better definition of characteristic radiological signs and better recognition of the significance of galactomannan (GM)...
RESOURCE LINE
VACCINE
January-March 2011
Prophylactic use of the quadrivalent HPV prevents external genital lesions in boys and men Giuliano et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med 2011;364(5):401-11,...
PRIORITY PRESS - 9th Canadian Immunization Conference (CIC)
Invasive Pneumococcal Disease in Older Adults
Quebec City, Quebec / December 5-8, 2010
Quebec City - Pneumococcal disease has a bimodal pattern of presentation, affecting the very young and the very old. In 2002, depending on the province, the 7-valent pneumococcal conjugate vaccine was incorporated into publicly funded...
PRIORITY PRESS - 9th Canadian Immunization Conference (CIC)
Adjuvanted Vaccines and the Immune System: Improving Response of Influenza Vaccines in the Elderly
Quebec City, Quebec / December 5-8, 2010
Quebec City - Adjuvants are often added to a vaccine in order to activate immune responses robust enough to protect against infection. In the elderly, the cytotoxic T-cell response to immunization is typically blunted, resulting in...
PRIORITY PRESS - 9th Canadian Immunization Conference (CIC)
HPV Vaccination for Males—Disease Burden Equivalent to Females
Quebec City, Quebec / December 5-8, 2010
Quebec City - Currently, vaccination against the human papillomavirus (HPV) is offered to females between 9 and 26 years of age, but uptake of the vaccine varies from province to province and many young women remain unvaccinated. Many now...
PRIORITY PRESS - 9th Canadian Immunization Conference (CIC)
Publicly-funded Childhood Immunization Programs: Update on the 13-valent Pneumococcal Vaccine
Quebec City, Quebec / December 5-8, 2010
Quebec City - The 7-valent pneumococcal conjugate vaccine (PCV7) has been part of the publicly-funded childhood immunization program for a number of years. With its high efficacy and uptake rates, the incidence of invasive pneumococcal...
PRIORITY PRESS - 9th Canadian Immunization Conference (CIC)
Enhancing Awareness and Uptake of Adult Vaccination
Quebec City, Quebec / December 5-8, 2010
Health care professionals (HCPs) with an interest in adult immunization should take advantage of every opportunity to discuss vaccination needs with their patients in order to enhance the likelihood that adults will be both interested in...
PRIORITY PRESS - 9th Canadian Immunization Conference (CIC)
Update on Clinical Findings from Meningococcal Vaccine Trials
Quebec City, Quebec / December 5-8, 2010
IMPACT (Immunization Monitoring Program, ACTive) surveillance data presented here at the CIC by Dr. Julie Bettinger, Assistant Professor, Vaccine Evaluation Centre, and Child and Family Research Institute, University of British Columbia...